Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

372 ARTÍCULOS , VIENDO DEL 256 AL 270

A phase 3 trial of IV immunoglobulin for Alzheimer disease

Relkin NR, Thomas RG, Rissman RA, Brewer JB, Rafii MS, van Dyck CH, Jack CR, Sano M, Knopman DS, Raman R, Szabo P, Gelmont DM, Fritsch S, Aisen PS; Alzheimer's Disease Cooperative Study.

Neurology. 2017 May 2;88(18):1768-1775. doi: 10.1212/WNL.0000000000003904. Epub 2017 Apr 5.

Neuropsychiatric Symptoms and Neuroimaging Biomarkers in Alzheimer Disease: "Which is the Cart and Which is the Horse?"

Geda YE, Krell-Roesch J, Sambuchi N, Michel BF.

Am J Geriatr Psychiatry. 2017 Jul;25(7):694-696. doi: 10.1016/j.jagp.2017.03.007. Epub 2017 Mar 16.

Aβ levels in the jugular vein and high molecular weight Aβ oligomer levels in CSF can be used as biomarkers to indicate the anti-amyloid effect of IVIg for Alzheimer's disease

Kasai T, Kondo M, Ishii R, Tanaka A, Ataka S, Shimada H, Tomiyama T, Mori H, Taylor M, Allsop D, Nakagawa M, Mizuno T, Tokuda T.

PLoS One. 2017 Apr 10;12(4):e0174630. doi: 10.1371/journal.pone.0174630. eCollection 2017.

[Correlation between Alzheimer disease and cataract]

Liu SS, Zhu SQ.

Zhonghua Yan Ke Za Zhi. 2017 Apr 11;53(4):314-316. doi: 10.3760/cma.j.issn.0412-4081.2017.04.016.

How the cognitive reserve interacts with β-amyloid deposition in mitigating FDG metabolism: An observational study

Carapelle E, Serra L, Modoni S, Falcone M, Caltagirone C, Bozzali M, Specchio LM, Avolio C.

Medicine (Baltimore). 2017 Apr;96(16):e5876. doi: 10.1097/MD.0000000000005876.

Applying fluid biomarkers to Alzheimer's disease

Zetterberg H.

Am J Physiol Cell Physiol. 2017 Jul 1;313(1):C3-C10. doi: 10.1152/ajpcell.00007.2017. Epub 2017 Apr 19.

Biomarkers for Early Diagnosis of Alzheimer's Disease in the Oldest Old: Yes or No?

Paolacci L, Giannandrea D, Mecocci P, Parnetti L.

J Alzheimers Dis. 2017;58(2):323-335. doi: 10.3233/JAD-161127.

Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database

Ben Bouallègue F, Mariano-Goulart D, Payoux P; Alzheimer’s Disease Neuroimaging Initiative (ADNI).

Alzheimers Res Ther. 2017 Apr 26;9(1):32. doi: 10.1186/s13195-017-0260-z.

Bryostatin Effects on Cognitive Function and PKCɛ in Alzheimer's Disease Phase IIa and Expanded Access Trials

Nelson TJ, Sun MK, Lim C, Sen A, Khan T, Chirila FV, Alkon DL.

J Alzheimers Dis. 2017;58(2):521-535. doi: 10.3233/JAD-170161.

Detectable Neuropsychological Differences in Early Preclinical Alzheimer's Disease: A Meta-Analysis

Duke Han S, Nguyen CP, Stricker NH, Nation DA.

Neuropsychol Rev. 2017 Dec;27(4):305-325. doi: 10.1007/s11065-017-9345-5. Epub 2017 May 11.

Evolving Relevance of Neuroproteomics in Alzheimer's Disease

Lista S, Zetterberg H, O'Bryant SE, Blennow K, Hampel H.

Methods Mol Biol. 2017;1598:101-115. doi: 10.1007/978-1-4939-6952-4_5.

Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease

Sala I, Illán-Gala I, Alcolea D, Sánchez-Saudinós MB, Salgado SA, Morenas-Rodríguez E, Subirana A, Videla L, Clarimón J, Carmona-Iragui M, Ribosa-Nogué R, Blesa R, Fortea J, Lleó A.

J Alzheimers Dis. 2017;58(3):909-918. doi: 10.3233/JAD-170073.

Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus report

Wallin A, Kapaki E, Boban M, Engelborghs S, Hermann DM, Huisa B, Jonsson M, Kramberger MG, Lossi L, Malojcic B, Mehrabian S, Merighi A, Mukaetova-Ladinska EB, Paraskevas GP, Popescu BO, Ravid R, Traykov L, Tsivgoulis G, Weinstein G, Korczyn A, Bjerke M, Rosenberg G.

BMC Neurol. 2017 May 23;17(1):102. doi: 10.1186/s12883-017-0877-3.

Altered peripheral profile of blood cells in Alzheimer disease: A hospital-based case-control study

Chen SH, Bu XL, Jin WS, Shen LL, Wang J, Zhuang ZQ, Zhang T, Zeng F, Yao XQ, Zhou HD, Wang YJ.

Medicine (Baltimore). 2017 May;96(21):e6843. doi: 10.1097/MD.0000000000006843.

PET Imaging for Early Detection of Alzheimer's Disease: From Pathologic to Physiologic Biomarkers

Bao W, Jia H, Finnema S, Cai Z, Carson RE, Huang YH.

PET Clin. 2017 Jul;12(3):329-350. doi: 10.1016/j.cpet.2017.03.001. Epub 2017 May 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias